Currently, the present study was the first to report that miR-9-3p could bind to MTDH to regulate the pathogenesis of breast cancer, and that there is a shared mechanism through which miR-9-3p and MTDH jointly regulate chemoresistance of breast cancer patients. Here, MTDH is linked to breast cancer.